Planned maintenance: The ODC Business service within the Health Business Services (HBS) portal will be unavailable from 7:00 pm AEST Thursday 23 July 2026 until 7:00 am AEST Friday 24 July 2026. All other services will remain available during this period.
News and media menu
Search
7 result(s) found, displaying 1 to 7
- Closed onConsultationConsultation on proposed Medicinal Cannabis Program fees and charges, including regulatory costs, licences, permits and reforms.
- Closed onConsultationConsultation on medicinal cannabis permit reform by the ODC, inviting stakeholder feedback to improve permit structure, design and administrative processes.
- Closed onConsultationConsultation on phase two of the kava pilot program, seeking feedback on risks, benefits and options for allowing commercial importation of kava into Australia.
- Closed onConsultationThe Office of Drug Control (ODC) is seeking comments from interested parties on the proposed medicinal cannabis cost recovery framework.
- Closed onConsultationProposed reforms to introduce a single medicinal cannabis licence and simplify the application process under the Narcotic Drugs Act.
- Closed onConsultationSubmissions received by the 2019 Review of the Narcotic Drugs Act are published on the Office of Drug Control website.
- Closed onConsultationConsultation on a proposed kava pilot program to ease restrictions on importing kava into Australia for personal use.